| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea803fedb641d0973cb43b9fbea9840f |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate |
2019-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca55d0d2a3214663971b0e3e80ad520
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6981178be890eca133dc2852d2a9262f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9ee14459309a18becf1f44122d51456 |
| publicationDate |
2021-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2019204127-B2 |
| titleOfInvention |
Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels |
| abstract |
In certain aspects, the present invention provides compositions and methods for nincreasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and nprimates, and particularly in humans. n5 |
| priorityDate |
2009-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |